This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lowe, D. C.
Right arrow Articles by Chatfield, S. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lowe, D. C.
Right arrow Articles by Chatfield, S. N.

 Previous Article  |  Next Article 

Infection and Immunity, February 1999, p. 700-707, Vol. 67, No. 2
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Characterization of Candidate Live Oral Salmonella typhi Vaccine Strains Harboring Defined Mutations in aroA, aroC, and htrA

David C. Lowe,1,2 Tor C. Savidge,3 Derek Pickard,2 Lars Eckmann,4 Martin F. Kagnoff,4 Gordon Dougan,5 and Steven N. Chatfield2,*

Department of Cellular Physiology, The Babraham Institute, Babraham, Cambridge CB2 4AT,1 Vaccine Research Unit, Medeva Group Research, Department of Biochemistry,2 and Department of Biochemistry,5 Imperial College of Science, Technology and Medicine, London SW7 2AY, and Institute of Child Health, University of Birmingham, Birmingham B16 8ET,3 United Kingdom, and Laboratory of Mucosal Immunology, Department of Medicine, University of California, San Diego, La Jolla, California4

Received 18 June 1998/Returned for modification 23 September 1998/Accepted 24 November 1998

The properties of two candidate Salmonella typhi-based live oral typhoid vaccine strains, BRD691 (S. typhi Ty2 harboring mutations in aroA and aroC) and BRD1116 (S. typhi Ty2 harboring mutations in aroA, aroC, and htrA), were compared in a number of in vitro and in vivo assays. BRD1116 exhibited an increased susceptibility to oxidative stress compared with BRD691, but both strains were equally resistant to heat shock. Both strains showed a similar ability to invade Caco-2 and HT-29 epithelial cells and U937 macrophage-like cells, but BRD1116 was less efficient at surviving in epithelial cells than BRD691. BRD1116 and BRD691 were equally susceptible to intracellular killing within U937 cells. Similar findings were demonstrated in vivo, with BRD1116 being less able to survive and translocate to secondary sites of infection when inoculated into the lumen of human intestinal xenografts in SCID mice. However, translocation of BRD1116 to spleens and livers in SCID mice occurred as efficiently as that of BRD691 when inoculated intraperitonally. The ability of BRD1116 to increase the secretion of interleukin-8 following infection of HT-29 epithelial cells was comparable to that of BRD691. Therefore, loss of the HtrA protease in S. typhi does not seem to alter its ability to invade epithelial cells or macrophages or to induce proinflammatory cytokines such as IL-8 but significantly reduces intracellular survival in human intestinal epithelial cells in vitro and in vivo.

* Corresponding author. Mailing address: Medeva Vaccine Research Unit, Department of Biochemistry, Imperial College of Science, Technology and Medicine, Exhibition Road, London SW7 2AY, United Kingdom. Phone: 0171 594 5211. Fax: 0171 584 9467. E-mail: Steve_Chatfield{at}medeva.ccmail.compuserve.com.

Infection and Immunity, February 1999, p. 700-707, Vol. 67, No. 2
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Bishop, A., House, D., Perkins, T., Baker, S., Kingsley, R. A., Dougan, G. (2008). Interaction of Salmonella enterica serovar Typhi with cultured epithelial cells: roles of surface structures in adhesion and invasion. Microbiology 154: 1914-1926 [Abstract] [Full Text]  
  • Sebkova, A., Karasova, D., Crhanova, M., Budinska, E., Rychlik, I. (2008). aro Mutations in Salmonella enterica Cause Defects in Cell Wall and Outer Membrane Integrity. J. Bacteriol. 190: 3155-3160 [Abstract] [Full Text]  
  • Bishop, A. L., Baker, S., Jenks, S., Fookes, M., Gaora, P. O, Pickard, D., Anjum, M., Farrar, J., Hien, T. T., Ivens, A., Dougan, G. (2005). Analysis of the Hypervariable Region of the Salmonella enterica Genome Associated with tRNAleuX. J. Bacteriol. 187: 2469-2482 [Abstract] [Full Text]  
  • Husseiny, M. I., Hensel, M. (2005). Rapid Method for the Construction of Salmonella enterica Serovar Typhimurium Vaccine Carrier Strains. Infect. Immun. 73: 1598-1605 [Abstract] [Full Text]  
  • Londono-Arcila, P., Freeman, D., Kleanthous, H., O'Dowd, A. M., Lewis, S., Turner, A. K., Rees, E. L., Tibbitts, T. J., Greenwood, J., Monath, T. P., Darsley, M. J. (2002). Attenuated Salmonella enterica Serovar Typhi Expressing Urease Effectively Immunizes Mice against Helicobacter pylori Challenge as Part of a Heterologous Mucosal Priming-Parenteral Boosting Vaccination Regimen. Infect. Immun. 70: 5096-5106 [Abstract] [Full Text]  
  • Qian, F., Pan, W. (2002). Construction of a tetR-Integrated Salmonella enterica Serovar Typhi CVD908 Strain That Tightly Controls Expression of the Major Merozoite Surface Protein of Plasmodium falciparum for Applications in Human Vaccine Production. Infect. Immun. 70: 2029-2038 [Abstract] [Full Text]  
  • Foulongne, V., Walravens, K., Bourg, G., Boschiroli, M. L., Godfroid, J., Ramuz, M., O'Callaghan, D. (2001). Aromatic Compound-Dependent Brucella suis Is Attenuated in Both Cultured Cells and Mouse Models. Infect. Immun. 69: 547-550 [Abstract] [Full Text]  
  • Resto-Ruiz, S. I., Sweger, D., Widen, R. H., Valkov, N., Anderson, B. E. (2000). Transcriptional Activation of the htrA (High-Temperature Requirement A) Gene from Bartonella henselae. Infect. Immun. 68: 5970-5978 [Abstract] [Full Text]  
  • McSorley, S. J., Jenkins, M. K. (2000). Antibody Is Required for Protection against Virulent but Not Attenuated Salmonella enterica Serovar Typhimurium. Infect. Immun. 68: 3344-3348 [Abstract] [Full Text]  
  • Tacket, C. O., Sztein, M. B., Wasserman, S. S., Losonsky, G., Kotloff, K. L., Wyant, T. L., Nataro, J. P., Edelman, R., Perry, J., Bedford, P., Brown, D., Chatfield, S., Dougan, G., Levine, M. M. (2000). Phase 2 Clinical Trial of Attenuated Salmonella enterica Serovar Typhi Oral Live Vector Vaccine CVD 908-htrA in U.S. Volunteers. Infect. Immun. 68: 1196-1201 [Abstract] [Full Text]  
  • Foulongne, V., Bourg, G., Cazevieille, C., Michaux-Charachon, S., O'Callaghan, D. (2000). Identification of Brucella suis Genes Affecting Intracellular Survival in an In Vitro Human Macrophage Infection Model by Signature-Tagged Transposon Mutagenesis. Infect. Immun. 68: 1297-1303 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»